logo
Select company
Select metric
$ -459KConsolidated Income
VS
Market
45
Sector
80
Industry
71
History
90
$ 1.04Close
$ 0.72 - $ 1.6 52-Week Range
Ticker Information

Ticker

TXMD

Company Name

THERAPEUTICSMD INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

THERAPEUTICSMD INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TXMD - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -459K
3/31/2025$ -2.1M
12/31/2024$ -2.18M
9/30/2024$ -3.32M
6/30/2024$ -6.08M
3/31/2024$ -7.41M
12/31/2023$ -10.28M
9/30/2023$ 68.31M
6/30/2023$ 42.72M
3/31/2023$ 157.41M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • THERAPEUTICSMD INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -190.87M.
  • Over the past 5 years, THERAPEUTICSMD INC's average Cons. Inc. has been $ -45.52M.
  • The median Cons. Inc. for THERAPEUTICSMD INC during this period was $ -8.04M
  • THERAPEUTICSMD INC reached its highest Cons. Inc. over the past 5 years at $ 157.41M.
  • The lowest Cons. Inc. recorded by THERAPEUTICSMD INC in the same timeframe $ -190.87M

THERAPEUTICSMD INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
LGVN : LONGEVERON INC $ -18.54MTRAW : TRAWS PHARMA INC $ -17.82MTNON : TENON MEDICAL INC $ -12.66MPRPH : PROPHASE LABS INC $ -41.45MCYCN : CYCLERION THERAPEUTICS INC $ -1.95MLUCY : INNOVATIVE EYEWEAR INC $ -7.73MINBS : INTELLIGENT BIO SOLUTIONS INC $ -10.6MSINT : SINTX TECHNOLOGIES INC $ -12.54MTLPH : TALPHERA INC $ -11.3MXBIO : XENETIC BIOSCIENCES INC $ -3.08M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

TXMD - Consolidated Income, Last 5 years

$ -190.87M

Minimum

Sep 30, 2020

$ 157.41M

Maximum

Mar 31, 2023

$ -45.52M

Average

$ -8.04M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.08M with a standard deviation of $ 116.5M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.08M
median$ -2.07M
std$ 116.5M